Prof. Dr. med. Dirk Arnold

Prof. Dr. med. Dirk Arnold is a highly established German cancer specialist with a strong reputation in medical oncology, hematology, and palliative medicine. He currently serves as Chefarzt at Asklepios Klinik Altona in Hamburg, where his official profile lists him in the department of oncology, hematology, palliative medicine, rheumatology, and pneumology. Asklepios also identifies him as Medizinischer Vorstand of the Asklepios Tumorzentrum Hamburg, and the group’s oncology reporting describes that tumor center as a coordinated network across Hamburg that brings together specialized expertise, cross-hospital tumor boards, and region-wide cancer care pathways. His formal specialist qualifications include hematology and internal oncology, internal medicine, and the additional qualification in palliative medicine. His career reflects both academic depth and high-level leadership in comprehensive cancer medicine. According to Asklepios, his previous positions included senior and leadership roles at the University Hospital Halle-Wittenberg, responsibility for the study center of the Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society, management of AIO Studien gGmbH in Berlin, medical leadership of the Hubertus Wald Tumorzentrum at UKE, and a director-level position in internal oncology at the Tumor Biology Clinic in Freiburg. He also served as Director of the Instituto CUF de Oncologia in Lisbon before returning to Germany to lead oncology at Asklepios Klinik Altona and help shape the development of the Asklepios Tumorzentrum Hamburg. This trajectory positions him as a physician with rare experience in university oncology, international cancer-center management, and large multicenter treatment structures. Prof. Arnold is especially well known for his work in gastrointestinal oncology and modern systemic cancer therapy. His research and publication record includes influential work on metastatic colorectal cancer, including a widely cited systematic review on treatment beyond second-line therapy and more recent consensus-based work on BRAF V600E-mutated metastatic colorectal cancer. His international standing is also reflected in official ESMO sources, which describe him as an Associate Editor for Annals of Oncology, a member of the ESMO Open editorial board, and part of the ESMO Gastro-Intestinal Tumours Faculty Group. ESMO’s 2023 Annual Report lists him as Chair of the Compliance Committee, and ESMO named him a Fellow of ESMO in 2024, underscoring his visibility and authority within European oncology. Prof. Dr. med. Dirk Arnold is a senior oncologist for complex cancer cases who combines evidence-based systemic therapy with interdisciplinary care planning and access to clinical innovation. His profile is particularly relevant for people looking for expert management of gastrointestinal cancers, hematologic malignancies, and advanced oncologic cases that require close coordination between diagnostics, drug therapy, supportive care, and palliative medicine.